. Dexamethasone enhances ras-recision gene expression in cultured murine fetal lungs: role in development. Am J Physiol Lung Cell Mol Physiol 279: L312-L318, 2000.-We have shown that dexamethasone (Dex) accelerates maturation and differentiation of cultured fetal murine lungs (Cilley RE, Zgleszewski SE, Krummel TM, and Chinoy MR. Surg Forum 47: 692-695, 1996). We now demonstrate that although Dex inhibits thinning of acinar walls and secondary septa formation, it does, however, promote lung growth. CD-1 murine fetal lungs were cultured for 7 days in the presence and absence of 10 nM Dex. Dex-modulated genes were investigated and identified by differential display of mRNAs performed with specific anchor primer H-T 11 G and 24 arbitrary primers. Thirty-five differentially expressed cDNAs were isolated, subcloned, sequenced, and identified through BLAST searches. One of these cDNAs, termed Dex2, with enhanced expression in Dex-treated lungs, had 100% similarity with ras-recision gene (rrg), also known as the lysyl oxidase (LOX) gene that encodes lysyl oxidase. LOX gene is very highly conserved, with significant sequence similarity among mouse, rat, and human. Two other cDNAs, termed Dex1 and Dex4, were also identified as rrg, with 92 and 97% sequence similarity with the existing data bank sequence of rrg. LOX enzyme is known to downregulate p21 ras protein and play a central role in the maturation of collagen and elastin in the extracellular matrix as well as modulate the cytoskeletal elements. Thus LOX may be important in lung developmental processes involving epithelial-mesenchymal interactions. lysyl oxidase; differential display of genes; epithelial-mesenchymal interactions; p21 ras protein; lung development THE REGULATION OF LUNG DEVELOPMENT is a complex process. A wide variety of genes and their products have been studied to increase understanding of their regulatory influences on maturation and differentiation of the developing lung. However, to date, the exact molecular mechanisms involved in the regulatory processes of lung development are not known.
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Glucocorticoids have been shown to accelerate fetal lung type II cell maturation, which is mediated in part via fibroblasts. It is also known that dexamethasone (Dex), a synthetic steroid, promotes lung maturation both in vitro and in vivo. Similarly, it has been previously demonstrated that Dex enhances lung maturational processes in murine fetal whole lungs in culture (5, 8) . Identifying and understanding the exact molecular pathways by which Dex carries out its effects may help in the design of new treatments for abnormally developing lungs, i.e., hypoplastic lungs. We propose that this lung organ culture model is useful for studying the isolated effects of Dex or other factors and thus helps identify the specific pathways involved in lung development.
In the present study, we employed the differential display technique to find differences in gene expression between untreated murine fetal lungs in culture (control) and those cultured in the presence of Dex. We isolated and identified the differentially expressed genes in these lungs by sequence similarity matches to existing genes in the GenBank database. Identifying the genes involved in lung developmental processes will open avenues for designing functional assays. We have standardized the technique of differential display of mRNAs in our laboratory, and, using this technique, our laboratory (4, 28) has previously demonstrated differential expression of genes between normal and nitrofen-induced hypoplastic murine fetal lungs.
METHODS

Animals
Time-dated pregnant CD-1 mice were euthanized via halothane overdose on gestational day (GD) 14. Fetuses were harvested via laparotomy and placed in cold saline (on ice). Median sternotomy was performed under a dissecting stereomicroscope, and heart-lung units were excised with the trachea and larynx intact. The hearts were removed and the tracheae were transected. Isolated murine fetal lungs were cultured for 7 days.
Culture Techniques
GD14 pseudoglandular lungs were placed individually onto 5-mm 2 sterile membranes (0.45-m pore size) that rested on sterile stainless steel wire mesh screens suspended in an organ culture dish filled with BGJ b culture medium. Culture medium was supplemented with 100 U/ml of penicillin G, 0.1 mg/ml of streptomycin, 0.25 mg/ml of amphotericin B, and 1 mg/l of sodium ascorbate at pH 7.4. Organ cultures were incubated in media with and without added factors such as Dex or retinoic acid (RA) for 7 days in a 95% air-5% CO 2 environment at 37°C. Media were changed daily under sterile conditions. The lungs were divided into two treatment groups (10 nM Dex and 10 Ϫ5 M RA) and one control group.
Morphology
The time 0 GD14 fetal mouse lungs and those cultured for 7 days as untreated controls or in the presence of 10 mM Dex or 10 Ϫ5 M RA were compared for gross morphology under a dissecting stereomicroscope (Nikon SMZ-U, Tokyo, Japan). Furthermore, one lung from each treatment group in each experiment was then fixed in 2.5% glutaraldehyde in 0.1 M cacodylate buffer at 4°C for 2 h and processed for resin embedding as previously described (2) . One-micrometer sections of lungs from the resin blocks were cut and stained with methylene blue. These sections were evaluated with light microscopy, and structural comparisons were made among the lungs cultured under different conditions.
Total RNA Extraction
Total RNA was extracted from cultured untreated control and Dex-treated lungs with the original acid guanidinium thiocyanate-phenol-chloroform extraction method of Chomczynski and Sacchi (7) or with its modified single-step, improved version (Ultraspec-II RNA Isolation Kit, Biotecx Laboratories, Houston, TX). After isolation and purification, the RNA was quantified at 260/280 nm with an ultraviolet (UV) spectrophotometer and stored at Ϫ80°C.
Differential Display Procedure
Differential display was carried out with the protocols in the RNAimage Kit (GenHunter, Nashville, TN) as described by Liang and Pardee (17) and previously published by our laboratory (4, 28) . All samples were run in duplicate. The experiments were performed twice, and the differential display of mRNAs was repeated with a second set of pooled lungs.
Reverse transcription of RNA. Reverse transcription (RT) of the purified total RNA from each experimental condition was performed. RT mixtures included distilled water (dH 2 O), RT buffer, 20 M deoxynucleotide triphosphate (dNTP), 0.2 g of RNA, and 0.2 M anchor primer H-T 11 G. Reactions ran as follows: 5 min at 65°C, 60 min at 37°C, 5 min at 75°C, and finally at 4°C. After 10 min at 37°C, 200 U of Moloney murine leukemia virus reverse transcriptase were added to each tube, and the incubation was continued for 60 min. Anchor primer G was randomly chosen for these studies out of the three available primers, A, C, and G.
Polymerase chain reaction. Polymerase chain reaction (PCR) of the RT mixtures was then carried out on each sample with the anchor primer G and one of 24 arbitrary primers as provided in the RNAimage kit. PCR mixtures included dH 2 
Ci of [␣-33 P]dATP (2,000 Ci/mmol), 1 U of AmpliTaq DNA polymerase, 0.2 M arbitrary primer, and the above RT mixtures. PCR was performed at the following settings on a thermocycler: 30 s at 94°C, 2 min at 40°C, 30 s at 72°C for 40 cycles, then 10 min at 72°C, and finally at 4°C. PCR products were loaded onto a 6% denaturing DNA-sequencing gel and electrophoresed for 3.5 h at 60-W constant power with maximum 1,700 V. Each gel was blotted onto Whatman 3M paper, covered with Saran wrap, and vacuum-dried at 80°C for 2 h. Dried gel was then exposed to X-ray film, and after 48 h, the autoradiogram was developed for each gel. Autoradiograms were checked for differentially expressed cDNA bands.
Reamplification of cDNA. Several cDNA bands showed differences in signal intensity between control and Dex, indicating induction, inhibition, enhancement, or reduction of expression by Dex compared with control. Differentially expressed cDNA bands of interest were cut from the dried gel and eluted in 100 l of dH 2 O. Each cDNA was precipitated in sodium acetate, 100% ethanol, and glycogen overnight at Ϫ80°C. Each precipitated cDNA was then centrifuged, and each cDNA pellet was washed with 85% ethanol and then dissolved in 10 l of dH 2 O. Next, each cDNA was reamplified with the same primer set that was used to obtain the respective bands. However, the dNTP concentration was changed to 20 M, and no isotope was added. PCR settings were identical to those described in Polymerase chain reaction. Reamplified cDNAs were run on 2% agarose gels stained with ethidium bromide. Reamplified cDNA was extracted from the agarose gel with a QIAEX Kit (QIAGEN, Chatsworth, CA).
cDNA Cloning PCR-amplified cDNA fragments were cloned with the protocols in the PCR-TRAP cloning system version 2.0 (GenHunter).
Ligation. cDNA fragments were ligated into the PCR-TRAP vector overnight (Ϸ21 h) at 16°C. Ligation reactions included dH 2 O, 300 ng of PCR-TRAP cloning vector, ligation buffer, PCR product, and 200 U/l of T4 DNA ligase.
Transformation and plating the cells. These protocols were based on the GenHunter PCR-TRAP cloning system protocol. Ligation mixture (10 l) was added to 100 l of GH-competent cells and incubated on ice for 45 min. Cells were heat shocked for 2 min at 42°C and then placed on ice. To these tubes, 400 l of Luria Bertani (LB) broth was added, then they were incubated for 60 min at 37°C. Two hundred microliters of cells were plated onto LB plates containing 10 g/ml of tetracycline. These were incubated overnight at 37°C, and the tetracycline-resistant colonies were scored the next morning as previously described (4) .
Plasmid purification, denaturation, and sequencing the cloned PCR products. Each colony was picked with a pipette tip and injected into 5 ml of LB culture broth containing 10 g/ml of tetracycline. Cultures were grown overnight at 37°C in a shaking incubator. Plasmid DNA (pDNA) was purified from the cultures with the protocol in the WizardPlus minipreps DNA purification system (Promega, Madison, WI) (4). Purified pDNA was denatured with 2 M sodium hydroxide and 2 mM EDTA for 30 min at 37°C. It was then precipitated with 3 M sodium acetate and 100% ethanol overnight at Ϫ80°C. pDNA was pelleted and dissolved in 7 l of dH 2 O.
pDNA was sequenced with the Sequenase version 2.0 DNA sequencing kit (US Biological, Cleveland, OH). A primer flanking the insert site was used to target the inserted DNA sequence. Sequences were read for each cDNA, and BLAST searches were performed for homology to existing sequences in the GenBank database (http://www.ncbi.nlm.nih.gov/cgibin/BLAST/nih-blast).
Verification of cDNA. Analyses of each of the reamplified cDNAs were done on 2% agarose gels. The ethidium bromidestained cDNA bands were visualized on an UV illuminator, cut out of the gel, and transferred to appropriately labeled microfuge tubes. Each cDNA was extracted from the gel with the QIAEX extraction kit (QIAGEN).
Northern Blot Analysis
We evaluated the dose response of Dex and RA and the time course for the effect of 10 nM Dex on lungs in culture after 7 days with Northern blot analysis. We extracted total RNA from control, Dex-treated, RA-treated, and normally developing lungs at various gestational stages and electrophoresed them on 1% agarose gels containing formaldehyde (1). Size-separated RNA was capillary transferred onto Gene Screen nylon membranes with 20ϫ saline-sodium citrate (SSC; 1ϫ SSC ϭ 150 mM NaCl and 15 mM sodium citrate). After an overnight transfer, the RNA was UV cross-linked to the membrane. [
32 P]dCTP (3,000 Ci/mmol) was used to generate the respective cDNA probes by random priming with Klenow enzyme. Membranes were prehybridized in a solution consisting of 5ϫ SSC, 5ϫ Denhardt's solution (1), 50% formamide, 1% SDS, and 10 mg/ml of denatured salmon sperm DNA at 42°C for at least 4 h. Overnight hybridization was performed with each probe (5 ϫ 10 5 counts ⅐ min Ϫ1 ⅐ ml Ϫ1 ) in the same buffer at 42°C. Posthybridization, the membranes were washed once with 2ϫ SSC and 0.1% SDS for 15 min at room temperature and twice with 0.1ϫ SSC and 0.1% SDS at 65°C for 30 min. They were then exposed to X-ray film. The signals were normalized to the signals obtained by hybridization to 28S rRNA.
Protein Determination
A minimum of three to five murine fetal lungs were pooled for preparing each sample. The lungs were homogenized on ice in PBS (pH 7.5) with protease inhibitors (1 g/ml of aprotinin, 2 g/ml of antipain, and 2 g/ml of leupeptin). Total protein concentrations were analyzed by taking aliquots for the Bio-Rad microassay for protein (Bio-Rad, Hercules, CA) with the Bradford method (3) as previously described (2, 5) . We also compared uncultured lungs from different developmental stages with the lungs cultured in the presence and absence of added factors such as Dex and RA.
Immunoblot Analyses
The immunoblot analysis of the lungs was carried out as previously described (6) . In this study, a mouse monoclonal antibody for p21 ras protein was used as a primary antibody (Santa Cruz Biotechnology, Santa Cruz, CA). This was done to indirectly verify our results on the rrg from differential display of mRNAs and to prove our hypothesis that because rrg was enhanced by Dex, it would reduce the p21 ras protein.
Statistical Analyses
For differential display of mRNAs, samples were run in duplicate, and the experiments were repeated twice to confirm the altered expression of mRNAs before the cDNAs were isolated and sequenced. Semiquantitative analyses of the immunoblots were done by calculating the means Ϯ SE. ANOVA was used to compare the data among the lungs cultured in the presence and absence of Dex as well as those cultured in the presence of other growth-and differentiationpromoting agents. When a difference was found, Dunnett's procedure for multiple comparisons was applied, with P set at 0.05 (20) .
RESULTS
Morphology
The gross morphology of cultured GD14 (time 0
Histologically, the coronal sections of time 0 lungs had the characteristic features of the pseudoglandular lungs (Fig. 1A) . After 7 days in culture, the untreated control lungs had poorly defined airway branching and little acinar development (Fig. 1B) . The lungs that were cultured in the presence of Dex had well-defined airways, thick acinar walls, and an absence of secondary septation; however, surfactant secretion was seen in the acinar spaces (Fig. 1C) . The lungs cultured in the presence of RA showed formation of saccular structures and significant thinning of the saccular walls. Unlike control and Dex-treated lungs, the RA-treated lungs also showed the formation of secondary septa.
Differentially Expressed Genes
The summary of the differentially expressed cDNAs in the murine fetal lungs cultured in the presence of Dex is given in Table 1 . Anchor primer G, in combination with one of the 24 arbitrary primers used, yielded a total of 35 differentially expressed cDNAs in the Dex-treated lungs compared with that in the untreated control lungs. Of these differentially expressed cDNAs, 13 were enhanced by Dex, 14 were reduced, 1 was induced, and 7 were inhibited compared with the control lungs (Table 1) . A representative autoradiograph demonstrating the differentially expressed cDNAs is shown in Fig. 2 .
On sequencing these differentially expressed cDNAs and identifying them through the BLAST searches, we found that of the 13 cDNAs that were enhanced by Dex, 3 specific cDNAs (which we named Dex1, Dex2, and Dex4) were identified as rrg or LOX gene (Table 2) . Dex2 had 100% sequence similarity with the existing LOX gene in the GenBank database (locus MUSLY-SOX, accession number M65142), and Dex1 and Dex4 had 92-97% similarity with the LOX gene. Further- http://ajplung.physiology.org/ more, the cDNA termed Dex3, which was induced by Dex, did not have any similarity with the existing gene sequences in the database. Therefore, we labeled it as an unknown gene (Table 2) . Another cDNA, termed UN1, which had a greater expression in untreated control lungs and was reduced by Dex in the cultured lungs, showed 98% sequence similarity with the fibroblast growth factor receptor 3 (FGFR3) gene ( Table 2) . Out of the cDNAs sequenced so far, ϳ25% have been false positive, and some others have been identified as the known structural genes, with low probability ratios. Several other cDNAs genes are currently being sequenced.
A Northern blot confirmation of rrg or LOX gene was carried out in normally developing lungs ranging in age from GD14 to neonates and also in in vitro control lungs. It was also carried out in the lungs treated with Dex and RA (Fig. 3) . The results clearly revealed upregulation of rrg by Dex. RA lungs demonstrated rrg expression similar to that in neonatal lungs, but this expression was significantly lower than that seen in the presence of Dex (Fig. 3) or even in the untreated control lungs.
Immunoblot Analyses
We carried out the Western blot analyses for p21 ras protein based on our hypothesis that because the rrg is enhanced by Dex, therefore p21 ras protein must be suppressed by Dex. Our immunoblot results revealed very little expression of p21 in developing lungs in vivo from GD14 to neonatal stage. Furthermore, all cultured lungs in the presence or absence of added factors showed higher levels of p21 (the Ras protein) compared with lungs developing in vivo. Our results showed that p21 ras gene product (protein) was downregulated by Dex in the lungs (Fig. 4) . This effect was complementary to the upregulation of rrg by Dex observed in our study of the differential display of mRNAs.
Others (13) ras protein levels in lungs treated with Dex with those treated with RA. At the dose of RA used in this study (10 Ϫ5 M), we observed increased levels of p21 ras protein in fetal lungs in culture (Fig. 4) . This observation suggested opposite effects of Dex and RA as well as indirectly corroborated our results from the differential display of mRNAs. In the lungs cultured in the presence of a combination of Dex and RA, the level of p21 ras protein was decreased (Fig. 4) , indicating the predominant effects of Dex on this protein.
DISCUSSION
We observed that Dex upregulated the rrg, also known as the LOX gene. LOX is a copper-dependent extracellular metalloenzyme that plays a central role in the cross-linking of collagen and elastin in the extracellular matrix (ECM) (i.e., maturation of collagen and elastin, as reviewed in Ref. 23) . LOX catalyzes the oxidation of lysine residues to ␣-aminoadipic ␦-semialdehyde. This is the first step in the covalent crosslinking of collagen and tropoelastin, and it results in the formation of insoluble collagen and elastin fibers in the ECM. LOX gene or rrg activity has been subsequently found to be increased in fibrotic lung disease (15) .
Because rrg plays a role in collagen-elastin crosslinking, we speculate that, in our study, upregulation of rrg by Dex resulted in formation of collagen and elastin fibers in ECM. Furthermore, these results corroborated our morphological observations, which demonstrated that there were thick septa present in these lungs, and that although the air spaces were larger, no secondary septa developed in Dex-treated lungs. One of the ECM components, elastin, is pivotal to the recoil of the lung vasculature and the alveolar walls. Abnormal elastin metabolism is associated with several diseases of the lung, including pulmonary hypertension (19) and emphysema (12) . In the absence of any pulmonary disease, the normal adult lung produces little elastin (24) ; therefore, lung function during one's lifetime depends on the elastin produced during development.
It has been shown that inhibitors of LOX administered during development result in abnormal air space morphology (11, 16) . This disruption leads to persistent abnormalities in alveolar size and number. Similar persistent effects have been reported in rats maintained on a copper-free diet, which reduced LOX activity (22) . These findings are consistent with a critical role for cross-linked elastin or collagen in fetal lung development. Increased activity of LOX may result in lung fibrosis, and inhibition of it may lead to abnormal air space morphology. Therefore, we suggest that maintaining the balance of the activity of LOX is crucial to the normal development of the lung.
cDNA to the human LOX has been isolated, and the gene has been mapped to human chromosome 5q23.3-q31.2 (14, 18) . It is a single gene in which the locus is distal to two tumor suppressor genes. Its structure has been partially characterized (25) . The mouse LOX gene has been mapped to mouse chromosome 18, distal to Camk-4 and proximal to li, extending a region that is syntenic with human chromosome 5q (21) . LOX gene is a single copy gene organized into seven exons and six introns, and it spans ϳ14 kb of the mouse genome (10) . The gene encodes two messages, sized at ϳ4.8 and 3.8 kb, that differ in length of the untranslated sequence at the 3Ј-end of the gene. All of the 3Ј-untranslated sequence and the polyadenylation signals are contained in exon 7; there is no evidence of alternate splicing (10) .
Through differential localization of Ras proteins and variations in their levels, it has been proposed that Ras proteins may be important during lung growth and differentiation. In fetal rat lungs, proliferative activity is known to decline near birth, followed by a gradual increase in cellular proliferation during the subsequent 8 days and a decline in basal levels by 15-18 days after birth (26) . During this period of substantial variation in proliferative activity, differences in both the protein content and localization of the different Ras proteins have been observed. Interestingly, the enzyme LOX (an rrg product) also appears to function as a phenotypic suppressor of the Fig. 2 . Representative autoradiograph of the differential display of cDNAs from Dex-treated and untreated murine fetal lungs in culture for 7 days. The anchor primer G was used in combination with arbitrary primers 38, 39, or 40 as shown. Differentially expressed genes were either enhanced (E), reduced (R), inhibited (In), or induced (Id) in the Dex-treated lungs with respect to the untreated control lungs. Note that box E shows enhanced expression of the rasrecision gene (rrg). Arrows, other differentially expressed genes. Samples were run in duplicate. ras oncogene product p21 in NIH/3T3 cells (10) . It is known that ras-transformed oncogenic cell detachment might be due to cytoskeletal and/or cell matrix alterations. Furthermore, filamentous intracellular localization of LOX in fibroblasts, smooth muscle cells, and some cloned cell lines demonstrated that it is associated with cytoskeletal protein (27) . These cytoskeletal elements involve microtubules, actin, and other microfilaments and intermediate filaments. The alterations in the cytoskeletal elements result in tissue-specific changes in cell shape, movement, and interactions with growth factors. Taken together, it is suggested that the ECM, along with the cytoskeleton and nuclear matrix, may regulate tissue-specific gene expression. Furthermore, it has been known that nontumorigenic reverants transfected with rrg (LOX gene) antisense constructs became retransformed and tumorigenic, and rrg message levels dropped to prereversion levels. It has been demonstrated that LOX or the rrg product has tumor suppressor activity and that it also plays a role in several pathological conditions. This indicates that the state of the connective tissue matrix, as influenced by LOX, is important in the prevention of the uncontrolled growth of oncogenic cells as well as in normal cell function.
We conducted a comparative study with and without added factors to the fetal lungs in culture and assessed the levels of p21 ras protein in these lungs. Because Dex upregulated rrg activity (a suppressor of p21 ras protein) in our differential display analyses, we expected to see downregulation of p21 ras protein in Dex-treated lungs. Our immunoblot data were supportive of this hypothesis. Furthermore, our laboratory (9) has previously shown that 10 nM Dex and 10 Ϫ5 M RA anatagonized several biochemical and morphological features in the developing lung. A comparison of p21 ras protein in lungs cultured in the presence of RA or Dex revealed that RA, unlike Dex, upregulated this protein. It was also noted that the p21 level was enhanced in vitro under all conditions. Addition of Dex or RA had specific influence on the levels of p21 protein. Functional assays assessing specific roles of LOX and p21 ras protein in the developing lungs will shed light on specific aspects of the regulation of normal lung development.
In summary, Dex treatment results in differential gene expression compared with that in control murine fetal lungs in culture. Based on our results and on existing literature, we speculate the following. 1) The regulation of LOX via Dex-enhanced expression affects the connective tissue matrix in the developing murine lung, which is indirectly supported by the presence of thick septa in these lungs. 2) Enhanced expression of rrg may be correlated to the increased thickness of the acinar septa and inhibition of secondary septa formation in the Dex-treated lungs.
3) It is plausible that in addition to accelerating maturation and differentiation of the developing lung, Dex may also adversely alter the connective tissue matrix in such a way that saccularization or alveolarization is inhibited, or it may contribute to fibrotic lung formation. Therefore, a balance in the ECM is crucial for promoting normal lung development. 4) From a therapeutic point of view, these observations raise a further question. Does continued influence by Dex on the developing lung in vitro or in vivo adversely affect the ECM (e.g., resulting in fibrosis or inhibition of alveolar formation) in addition to its desired effect of accelerating lung epithelial cell maturation and differentiation? Fig. 3 . Northern blot hybridization of the rrg (Dex2) that confirms the enhanced expression of rrg in Dex-treated lungs compared with that in control murine fetal lungs after 7 days in culture. In vivo developing lungs from Gd14, -16, -18, and -19 as well as from neonates (Neo) were compared with lungs cultured in the presence and absence of Dex or RA or with untreated lungs in culture. These signals were normalized to 28S rRNA. ras protein in cultured lungs and uncultured lungs at various stages of gestation. The blot reveals low expression of p21 in in vivo developing lungs. All the lungs in culture, in both the presence and absence of added factors, showed higher expression of p21. Compared with cultured control lungs and those treated with RA, the lungs treated with Dex had reduced levels of p21. When Dex was given in combination with RA, it lowered the p21 protein in the developing lungs. Thus the immunoblot results prove our hypothesis that because Dex enhances expression of ras-recision gene, it reduces p21 protein. Sequence similarities of differentially expressed cDNAs were obtained through BLAST searches. cDNA clones were labeled as Dex1, Dex2, Dex3, and Dex4 (dexamethasone) or UN (untreated control) based on the respective bands cut from the differential display gel. FGFR3, fibroblast growth factor receptor 3. Several other differentially expressed genes are being sequenced and identified currently.
